I don't know there will be a CR. It seems to me that from the below comment regarding this half of the FY, there is an eagerness to make a deal. Potentially discussions may have already started, now it's all about waiting for the data:
Sharing data and discussions on the Company’s antiviral programs including the HIV-1 and COVID-19 Phase
2 clinical trials with potential pharmaceutical company partners with a view to commercialisation of the
Company’s antiviral intellectual property.
Ann: Half Yearly Report and Accounts, page-69
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
